Celtaxsys Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Out of Business

Celtaxsys General Information

Description

Developer of a novel therapeutics designed to treat inflammatory disease through regulation of immune cell migration and activation. The company is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer, and inflammatory and autoimmune diseases, enabling patients to be treated with rare and serious inflammatory conditions.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 201 17th Street
  • Suite 530
  • Atlanta, GA 30363
  • United States
+1 (470)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 201 17th Street
  • Suite 530
  • Atlanta, GA 30363
  • United States
+1 (470)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celtaxsys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 22-Oct-2020 Completed Out of Business
6. Later Stage VC (Series E) 18-Dec-2017 Completed Generating Revenue
5. Later Stage VC (Series D) 08-Jun-2015 Completed Generating Revenue
4. Later Stage VC (Series C) 27-Oct-2010 Completed Generating Revenue
3. Early Stage VC 07-May-2009 Completed Generating Revenue
2. Early Stage VC (Series B) 14-May-2008 $3.7M $8.9M Completed Generating Revenue
1. Early Stage VC (Series A) 22-Jul-2005 $5.19M $5.19M Completed Startup
To view Celtaxsys’s complete valuation and funding history, request access »

Celtaxsys Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
To view Celtaxsys’s complete cap table history, request access »

Celtaxsys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel therapeutics designed to treat inflammatory disease through regulation of immune cell migration and
Drug Discovery
Atlanta, GA
10 As of 2010

Cambridge, MA

Austin, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Celtaxsys Competitors (22)

One of Celtaxsys’s 22 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Formerly VC-backed Cambridge, MA
XBiotech Corporation Austin, TX
Toleranzia Private Equity-Backed Gothenburg, Sweden
Aclaris Therapeutics Formerly VC-backed Wayne, PA
Corbus Pharmaceuticals Holdings Formerly VC-backed Norwood, MA
You’re viewing 5 of 22 competitors. Get the full list »

Celtaxsys Patents

Celtaxsys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10898484-B2 Method of reducing pulmonary exacerbations in respiratory disease patients Active 31-May-2018
US-20190365750-A1 Method of reducing pulmonary exacerbations in respiratory disease patients Active 31-May-2018
WO-2019232306-A1 Method of reducing pulmonary exacerbations in respiratory disease patients Inactive 31-May-2018
US-20190161471-A1 Inhibitors of leukotriene a4 hydrolase Inactive 09-Dec-2016
WO-2018107153-A1 Inhibitors of leukotriene a4 hydrolase Inactive 09-Dec-2016 C07D401/06
To view Celtaxsys’s complete patent history, request access »

Celtaxsys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celtaxsys FAQs

  • When was Celtaxsys founded?

    Celtaxsys was founded in 2004.

  • Where is Celtaxsys headquartered?

    Celtaxsys is headquartered in Atlanta, GA.

  • What is the size of Celtaxsys?

    Celtaxsys has 10 total employees.

  • What industry is Celtaxsys in?

    Celtaxsys’s primary industry is Drug Discovery.

  • Is Celtaxsys a private or public company?

    Celtaxsys is a Private company.

  • What is Celtaxsys’s current revenue?

    The current revenue for Celtaxsys is .

  • How much funding has Celtaxsys raised over time?

    Celtaxsys has raised $75.2M.

  • Who are Celtaxsys’s competitors?

    AnTolRx, XBiotech, Toleranzia, Aclaris Therapeutics, and Corbus Pharmaceuticals Holdings are some of the 22 competitors of Celtaxsys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process